Minnesota's New Prescription Drug Price Transparency Reporting: What You Need to Know | by: Sumeet Singh, Founder & Chairman | Article Posted: November 6, 2023 | In recent years, the transparency surrounding prescription drug pricing has become a focal point for...
The NABP Sheds Light on “Cancelled” VAWD Applications The NABP has clarified that a "Cancelled” application does not equate to a “Denied”...
BREAKING: NABP Cancels First VAWD Application Citing Pharmacy Purchases In a stunning reversal of their existing course of conduct, the NABP has...
OptumRX Enforces VAWD Requirement A Florida pharmacy disclosed to the Five Rivers team on February 15, 2017 that OptumRX is now enforcing its...
VAWD Program Generates *Estimated* $5.79 Million in 4 Months This blog post focuses on the financials behind the VAWD Program. Five Rivers estimates...
NABP's Potential Double Standard In this week's post, we explore how the NABP is potentially setting a double-standard as it applies its rules to...
NABP Launches VDIP Accreditation for OTC Suppliers NABP launched VDIP Accreditation for diagnostic over-the-counter (OTC) medical devices on...
